Hikma Pharmaceutical | HIK - Operating Expenses

Stock Price
1,577.50
Daily Change
23.50 1.51%
Monthly
3.31%
Yearly
-30.87%
Q1 Forecast
1,498.57

Hikma Pharmaceutical reported $642M in Operating Expenses for its fiscal semester ending in June of 2025.





Operating Expenses Change Date
Almirall EUR 517.43M 43.18M Jun/2025
argenx SE USD 776.99M 32.87M Sep/2025
AstraZeneca USD 16.69B 5.74B Sep/2025
Autolus Therapeutics Ltd USD 82.61M 8.39M Jun/2025
Bayer EUR 10.2B 523M Sep/2025
Fresenius EUR 4.91B 110M Sep/2025
Galapagos EUR 112.83M 9.48M Sep/2025
Genmab DKK 565M 38M Jun/2025
GlaxoSmithKline GBP 5.76B 203M Sep/2025
GRIFOLS EUR 1.51B 28.3M Sep/2025
Hikma Pharmaceutical USD 642M 663M Jun/2025
Lonza CHF 3.09B 564M Dec/2024
Merck EUR 4.11B 117M Sep/2025
Orion EUR 302.2M 9.7M Sep/2025
Recordati EUR 466.68M 27.25M Sep/2025
Roche Holding CHF 21.01B 10.84B Dec/2025
Sanofi EUR 10.51B 1.21B Dec/2025
UCB EUR 2.36B 108M Dec/2024